DCTH Trade Setup – Key Levels! 📊
SL (Stop-Loss): $15.18 🔴
Entry: $16.13 🟡
T1 (Target 1): $17.19 🟢
T2 (Target 2): $18.28 🟢
👉 Monitor for confirmation of the breakout and manage risk wisely. 💹
#DCTH #StockTrading #TechnicalAnalysis #BreakoutTrade #SupportAndResistance #TradingStrategy #StockMarket #SwingTrading #ChartPatterns #D
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.97 USD
−26.39 M USD
37.20 M USD
28.00 M
About Delcath Systems, Inc.
Sector
Industry
CEO
Gerard J. Michel
Website
Headquarters
Queensbury
Founded
1988
FIGI
BBG000BY2VF5
Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.
$DCTH Banking On Dilutive MetastasisAlthough FDA approval is a promising sign to invest in biotech stocks, that may not be the case with Delcath Systems, Inc. (NASDAQ: DCTH) whose treatment for a form of metastatic melanoma – Heozato Kit – was recently approved by the FDA. The promising biotech company is suffering from high cash burn
DCTH REKT Alot Of PeopleHello,
What is DCTH?
Delcath Systems, Inc. Delcath Systems, Inc. (NASDAQ: DCTH) is a publicly traded specialty pharmaceutical and medical device company that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or r
DCTH: Another GAP Up Play in the WorksNASDAQ:DCTH
DCTH is a wild lil' Penny Stock that is already gapping up in pre-Market. This company is really trying to rally back up over $1, and has seen a bunch of strong plays since posting its strong earnings report.
Although I'm a bit skeptical for any long-term plays with this, I'm expecti
DCTH Bullish because of ascending triangleHello everyone
Here is my analysis on the DCTH stock. For me it looks very bullish because of the ascending triangle. As I think we will reach new All time highs soon!
Dont forget all the news, and the thing that people say they maybe get delisted. I don't think so, I think their drug will get FDA
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of DCTH is 12.11 USD — it has decreased by −0.12% in the past 24 hours. Watch Delcath Systems, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Delcath Systems, Inc. stocks are traded under the ticker DCTH.
DCTH stock has risen by 4.47% compared to the previous week, the month change is a −17.56% fall, over the last year Delcath Systems, Inc. has showed a 125.09% increase.
We've gathered analysts' opinions on Delcath Systems, Inc. future price: according to them, DCTH price has a max estimate of 25.00 USD and a min estimate of 21.00 USD. Watch DCTH chart and read a more detailed Delcath Systems, Inc. stock forecast: see what analysts think of Delcath Systems, Inc. and suggest that you do with its stocks.
DCTH reached its all-time high on Apr 29, 2010 with the price of 515,872,000,000.00 USD, and its all-time low was 2.25 USD and was reached on Nov 14, 2023. View more price dynamics on DCTH chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
DCTH stock is 2.80% volatile and has beta coefficient of 1.98. Track Delcath Systems, Inc. stock price on the chart and check out the list of the most volatile stocks — is Delcath Systems, Inc. there?
Today Delcath Systems, Inc. has the market capitalization of 403.20 M, it has increased by 9.10% over the last week.
Yes, you can track Delcath Systems, Inc. financials in yearly and quarterly reports right on TradingView.
Delcath Systems, Inc. is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
DCTH earnings for the last quarter are −0.11 USD per share, whereas the estimation was −0.00059 USD resulting in a −18.67 K% surprise. The estimated earnings for the next quarter are 0.021 USD per share. See more details about Delcath Systems, Inc. earnings.
Delcath Systems, Inc. revenue for the last quarter amounts to 15.10 M USD, despite the estimated figure of 13.62 M USD. In the next quarter, revenue is expected to reach 16.73 M USD.
DCTH net income for the last quarter is −3.40 M USD, while the quarter before that showed 1.86 M USD of net income which accounts for −282.30% change. Track more Delcath Systems, Inc. financial stats to get the full picture.
No, DCTH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 26, 2025, the company has 96 employees. See our rating of the largest employees — is Delcath Systems, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Delcath Systems, Inc. EBITDA is −12.09 M USD, and current EBITDA margin is −32.74%. See more stats in Delcath Systems, Inc. financial statements.
Like other stocks, DCTH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Delcath Systems, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Delcath Systems, Inc. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Delcath Systems, Inc. stock shows the sell signal. See more of Delcath Systems, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.